200 related articles for article (PubMed ID: 36211108)
1. Primary Anaplastic Lymphoma Kinase (ALK)-Negative Anaplastic Large Cell Lymphoma (ALCL) Presenting as Perforation Peritonitis: A Case Report and Management Principles.
Sanker V; Mohamed A; Pranala M; Jadhav C; Tharakan V
Cureus; 2022 Sep; 14(9):e28738. PubMed ID: 36211108
[TBL] [Abstract][Full Text] [Related]
2. Systemic and primary cutaneous anaplastic large cell lymphoma: Clinical features, morphological spectrum, and immunohistochemical profile.
Kwatra KS; Paul PAM; Calton N; John JM; Cotelingam JD
South Asian J Cancer; 2017; 6(3):129-131. PubMed ID: 28975123
[TBL] [Abstract][Full Text] [Related]
3. ALK-Negative Anaplastic Large Cell Lymphoma: Current Concepts and Molecular Pathogenesis of a Heterogeneous Group of Large T-Cell Lymphomas.
Pina-Oviedo S; Ortiz-Hidalgo C; Carballo-Zarate AA; Zarate-Osorno A
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572893
[TBL] [Abstract][Full Text] [Related]
4. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
Stein H; Foss HD; Dürkop H; Marafioti T; Delsol G; Pulford K; Pileri S; Falini B
Blood; 2000 Dec; 96(12):3681-95. PubMed ID: 11090048
[TBL] [Abstract][Full Text] [Related]
5. ALCL by any other name: the many facets of anaplastic large cell lymphoma.
Irshaid L; Xu ML
Pathology; 2020 Jan; 52(1):100-110. PubMed ID: 31706671
[TBL] [Abstract][Full Text] [Related]
6. Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.
Oregel KZ; Everett E; Zhang X; Nagaraj G
Expert Rev Anticancer Ther; 2016; 16(3):279-83. PubMed ID: 26809026
[TBL] [Abstract][Full Text] [Related]
7. CD30-Positive Anaplastic Lymphoma Kinase-Negative Systemic Anaplastic Large-Cell Lymphoma in a 9-Year-Old Boy.
Kim JE; Oh EH; Ro YS; Ko JY
Ann Dermatol; 2016 Jun; 28(3):371-4. PubMed ID: 27274637
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic Large Cell Lymphoma: Molecular Pathogenesis and Treatment.
Zhang XR; Chien PN; Nam SY; Heo CY
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406421
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management.
Shustov A; Soma L
Cancer Treat Res; 2019; 176():127-144. PubMed ID: 30596216
[TBL] [Abstract][Full Text] [Related]
10. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
[TBL] [Abstract][Full Text] [Related]
11. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
[TBL] [Abstract][Full Text] [Related]
12. ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient.
Pulitzer M; Ogunrinade O; Lin O; Steinherz P
J Cutan Pathol; 2015 Mar; 42(3):182-187. PubMed ID: 25404214
[TBL] [Abstract][Full Text] [Related]
13. Advances in the treatment and prognosis of anaplastic lymphoma kinase negative anaplastic large cell lymphoma.
Wang X; Wu J; Zhang M
Hematology; 2019 Dec; 24(1):440-445. PubMed ID: 31072226
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic features of 66 cases of anaplastic lymphoma kinase positive and negative systemic anaplastic large cell lymphoma: a comparative study].
Shi Y; Chen G; Zhou XG; Gong LP; Yu R; Zheng YY; Xie JL; Jin Y
Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):235-9. PubMed ID: 20654121
[TBL] [Abstract][Full Text] [Related]
15. Anaplastic large cell lymphoma ALK-negative clinically mimicking alcoholic hepatitis - a review.
de Campos FPF; Felipe-Silva A; Zerbini MCN
Autops Case Rep; 2013; 3(3):11-19. PubMed ID: 31528614
[TBL] [Abstract][Full Text] [Related]
16. Primary Gastric ALK-negative EBV-negative Anaplastic Large Cell Lymphoma Presenting with Iron Deficiency Anemia.
Zhang W; Burton S; Wu S; Qian X; Rajeh MN; Schroeder K; Shuldberg M; Merando A; Lai JP
In Vivo; 2017; 31(4):701-704. PubMed ID: 28652442
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.
Eckerle S; Brune V; Döring C; Tiacci E; Bohle V; Sundström C; Kodet R; Paulli M; Falini B; Klapper W; Chaubert AB; Willenbrock K; Metzler D; Bräuninger A; Küppers R; Hansmann ML
Leukemia; 2009 Nov; 23(11):2129-38. PubMed ID: 19657361
[TBL] [Abstract][Full Text] [Related]
18. Brain metastasis of ALK positive anaplastic large cell lymphoma after a long-term disease free survival in an old adult.
Wang CX; Wang H; Li J; Ma HH; Yu B; Shi SS; Zhou XJ; Shi QL
Int J Clin Exp Pathol; 2014; 7(3):1182-7. PubMed ID: 24696735
[TBL] [Abstract][Full Text] [Related]
19. Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma.
Gleason L; Afifi L; Banner L; Talasila S; Joffe D; Bhatti S; Alpdogan O; Porcu P; Nikbakht N
Mol Clin Oncol; 2024 May; 20(5):35. PubMed ID: 38596625
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]